Documents

Policy Brief Issue 186 : Value Distribution in New Branded Medicines: How Much Benefits Patients Versus Manufacturers?

Policy Brief Issue 182: Cost-Effectiveness of Cascade Testing for Familial Hypercholesterolemia in Thailand: A Comparative Analysis of Genome Sequencing Methods Across Development Stages

Policy Brief Issue 31: Strategies for Sustainable Access: Unpacking Managed Entry Agreements (MEAs) and Innovative Medicine Access

Policy Brief Issue 29: Unveiling Thailand’s Path to Open Data for Health Policy

Policy Brief Issue 28: Implementation of a Virtual Consultation Platform (VCP) for Healthcare Providers Integrated with a Patient-Facing Mobile Application

Factsheet: Who are the high cost users in Thailand’s Universal Coverage Scheme and how can we help?

Thinking of Creating a Chatbot in Public Health? Here are some tips and tricks for you

Recommended Health Screening Packages under Universal Health Coverage

Navigating the Landscape of Digital Health: Indonesia

Navigating the Landscape of Digital Health: Singapore

Navigating the Landscape of Digital Health: United Kingdom

Full report: A Cost Analysis of Key Population Interventions to Fast Track the End of the HIV Epidemic in Thailand

Full report: Guidance on use of modelling for policy responses to COVID-19

A Retrospective Secondary Data Analysis of Telemedicine Service Utilization (2020-2023) Among Patients Covered By The Universal Coverage Scheme in Thailand

Telemedicine Utilization in Tertiary, Specialized, and Secondary Hospitals in Thailand

Telemedicine utilization patterns and implications amidst covid-19 outbreaks in Thailand under public universal coverage scheme

การประเมินเทคโนโลยีด้านสุขภาพโดยคณะทำงานด้านเศรษฐศาสตร์สาธารณสุข ภายใต้คณะอนุกรรมการพัฒนาบัญชียาหลักแห่งชาติ รอบปี พ.ศ. 2559-2561

การจัดหายาของโรงพยาบาลรัฐตามพระราชบัญญัติการจัดซื้อจัดจ้างและการบริหารพัสดุภาครัฐ พ.ศ.2560

How Many People Experience Unsafe Medical Care in Thailand, and How Much Does It Cost under Universal Coverage Scheme?

Health economic evaluations for Indonesia: a systematic review assessing evidence quality and adherence to the Indonesian Health Technology Assessment (HTA) Guideline

Economic Evaluation of Evusheld® for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand

Economic Analysis of Border Control Policies during COVID-19 Pandemic: A Modelling Study to Inform Cross-Border Travel Policy between Singapore and Thailand

Cost-Effectiveness Analysis of COVID-19 Vaccine Booster Dose in the Thai Setting during the Period of Omicron Variant Predominance

Special English Edition of HITAP newsletter (Jan-Apr 2016) : Priority Setting for Universal Health Coverage

Annual report 2015

Portfolio Health Intervention and Technology Assessment Program (HITAP)

Annual report 2011

Annual report 2010

Annual report 2009

19th HTAsiaLink Newsletter: Highlights from the 11th HTAsiaLink Annual Conference in Malaysia

18th HTAsiaLink Newsletter: The Role of HTA in the New Normal: Driving the post-COVID health systems through evidence-informed decisions

17th HTAsiaLink Newsletter: Bridge to the Future – Horizon Scanning for Emerging Health Technology

16th HTAsiaLink Newsletter: Lessons from the Pandemic for HTA

15th HTAsiaLink Newsletter: How to optimise HTA usage in healthcare crisis?

A Study Visit Report: Unpacking Thailand’s Medicine Pricing, Reimbursement Policy and Benefits Package

Report: Unit for Health Evidence and Policy (UHEP) Second Stakeholder Consultation and HTA Topic Prioritisation Workshop

Mission Report: Improving Decision-making Through Better Tools

Mission Report: South-South Collaboration: Experience Sharing on HTA Development

Mission Report: HTA Development Activities in Indonesia